首页> 外文期刊>The Journal of Physiology >Cortical actin regulation modulates vascular contractility and compliance in veins
【24h】

Cortical actin regulation modulates vascular contractility and compliance in veins

机译:皮质肌动蛋白调节调节血管收缩和顺应性

获取原文
获取原文并翻译 | 示例
       

摘要

The literature on arterial mechanics is extensive, but far less is known about mechanisms controlling mechanical properties of veins. We use here a multi-scale approach to identify subcellular sources of venous stiffness. Portal vein tissue displays a severalfold decrease in passive stiffness compared to aortic tissues. The -adrenergic agonist phenylephrine (PE) increased tissue stress and stiffness, both attenuated by cytochalasin D (CytoD) and PP2, inhibitors of actin polymerization and Src activity, respectively. We quantify, for the first time, cortical cellular stiffness in freshly isolated contractile vascular smooth muscle cells using magnetic microneedle technology. Cortical stiffness is significantly increased by PE and CytoD inhibits this increase but, surprisingly, PP2 does not. No detectable change in focal adhesion size, measured by immunofluorescence of FAK and zyxin, accompanies the PE-induced changes in cortical stiffness. Probing with phospho-specific antibodies confirmed activation of FAK/Src and ERK pathways and caldesmon phosphorylation. Thus, venous tissue stiffness is regulated both at the level of the smooth muscle cell cortex, via cortical actin polymerization, and by downstream smooth muscle effectors of Src/ERK signalling pathways. These findings identify novel potential molecular targets for the modulation of venous capacitance and venous return in health and disease.
机译:关于动脉力学的文献很多,但是关于控制静脉的机械特性的机制知之甚少。我们在这里使用多尺度方法来识别静脉僵硬的亚细胞来源。与主动脉组织相比,门静脉组织的被动僵硬程度降低了几倍。肾上腺素能激动剂去氧肾上腺素(PE)增加了组织应激和硬度,两者均被细胞松弛素D(CytoD)和PP2(肌动蛋白聚合抑制剂和Src活性)分别减弱。我们首次使用磁性微针技术量化了新鲜分离的收缩性血管平滑肌细胞中的皮质细胞刚度。 PE显着增加了皮质的刚度,而CytoD抑制了这种增加,但令人惊讶的是PP2却没有。通过PEK诱导的皮质硬度变化,未通过FAK和zyxin的免疫荧光法检测到粘着斑大小的可检测变化。用磷酸特异性抗体探查证实了FAK / Src和ERK途径的激活和caldesmon磷酸化。因此,通过皮层肌动蛋白聚合以及在Src / ERK信号通路的下游平滑肌效应子,在平滑肌细胞皮层的水平调节静脉组织的刚度。这些发现确定了在健康和疾病中调节静脉容量和静脉回流的新型潜在分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号